Preventing insomnia in at-risk youth
Prevention of Insomnia in At-risk Youth: A Randomized Controlled Trial Comparing Cognitive Behavioural Prevention Programme for Insomnia With Active Control Condition
NA · Chinese University of Hong Kong · NCT05451524
This study is testing a program to help young people aged 15-24 who are at risk of insomnia to see if it can prevent them from developing sleep problems in the future.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 204 (estimated) |
| Ages | 15 Years to 24 Years |
| Sex | All |
| Sponsor | Chinese University of Hong Kong (other) |
| Locations | 1 site (Shatin, NT) |
| Trial ID | NCT05451524 on ClinicalTrials.gov |
What this trial studies
This study conducts a randomized controlled trial comparing a cognitive behavioral insomnia prevention program with an active control group for youths aged 15-24 who are at risk of developing insomnia. The program targets those with subclinical insomnia symptoms and a family history of insomnia disorders. By addressing insomnia early, the study aims to reduce the long-term negative impacts associated with this condition, such as cognitive impairment and increased risk of depression and anxiety. The findings could lead to scalable prevention strategies for insomnia in this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates are youths aged 15-24 with subclinical insomnia symptoms and a family history of insomnia disorders.
Not a fit: Patients with a current or past history of neuropsychiatric disorders or diagnosed sleep disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly reduce the incidence of insomnia and its associated negative outcomes in at-risk youth.
How similar studies have performed: Other studies have shown success with cognitive behavioral approaches for insomnia, indicating potential for this prevention program.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Youth aged between 15-24 years (as defined by WHO); * Written informed consent of participation into the study is given by youth and his/her parents if under 18 years old; In addition, individual assent will also be obtained for subjects under age 18 years old; * Have subclinical insomnia symptoms (at least once a month but less than 3 times/week in the past one month); * At least one of the biological parents with current or lifetime history of insomnia disorder as defined by DSM-V diagnostic criteria. Exclusion Criteria: * A current or past history of neuropsychiatric disorder(s); * A prominent medical condition or taking medication with potential side effects that may influence sleep quantity and quality; * Having a diagnosed sleep disorder that may potentially contribute to the disruption of sleep quantity and quality as ascertained by both Structured Diagnostic Interview for Sleep patterns and Disorders (DISP) such as insomnia, delayed sleep phase and narcolepsy, restless leg syndrome; * Having a clinically significant suicidality (presence of suicidal ideation with a plan or an attempt); * Currently receiving any structured psychotherapy; * With hearing or speech deficit; * Trans-meridian flight in the past 3 months and during the study.
Where this trial is running
Shatin, NT
- Department of Psychiatry — Shatin, NT, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: NGAN YIN CHAN, PhD — Chinese University of Hong Kong
- Study coordinator: NGAN YIN CHAN, PhD
- Email: rachel.chan@cuhk.edu.hk
- Phone: +852 39197792
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Insomnia, insomnia, prevention, at-risk youth, cognitive behavioral approach, active control group